Ligand Pharmaceuticals Incorporated · NASDAQ:LGND
Janus Henderson Group PLC reported a 5.50% stake in Ligand Pharmaceuticals Incorporated (Schedule 13G/A)
Event Jun 30, 2025 · Filed Aug 14, 2025
Janus Henderson Group PLC reported a 5.50% stake in Ligand Pharmaceuticals Incorporated, 1,060,734 shares, as a passive investor on Jun 30, 2025. Filed Aug 14, 2025 (Schedule 13G/A).
- Stake
- 5.50%
- Shares
- 1,060,734
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| JANUS HENDERSON GROUP PLC | 5.50% | 1,060,734 |
Source
Related
- Ligand Pharmaceuticals Incorporated
- Janus Henderson Group PLC
- Ligand Pharmaceuticals Incorporated shareholders
- Schedule 13G/A · Janus Henderson Group PLC · Nov 14, 2025
- Schedule 13G/A · Janus Henderson Group PLC · May 14, 2025
- Schedule 13G/A · Janus Henderson Group PLC · Feb 14, 2025
- Form 4 · Reardon Andrew · Oct 6, 2026
- Form 4 · Zimmermann Martine · Sep 24, 2026
- Form 4 · Zimmermann Martine · Sep 14, 2026
- Form 4 · Reardon Andrew · Sep 8, 2026
- Form 4 · Espinoza Octavio · Aug 14, 2026